THE MCMANUS GROUP for ELI LILLY AND COMPANY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support for H.R. 1548, "Pathway for Biosimilars Act." Follow-on biologics provisions in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Medicare/Medicaid MMM
Opposition to Medicare rebates in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act." Coding and payment for follow-on biologics in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.